Mail

Canada markets closed

S&P/TSX
22,284.76
+41.42(+0.19%)
S&P 500
5,308.15
+61.47(+1.17%)
DOW
39,908.00
+349.89(+0.88%)
CAD/USD
0.7351
+0.0026(+0.35%)
CRUDE OIL
78.88
+0.86(+1.10%)
Bitcoin CAD
89,565.46
+5,796.49(+6.92%)

MARKETS LIVE BLOG

STOCKS JUMP AFTER U.S. INFLATION REPORT RELEASE

Roundhill Magnificent Seven ETF hits all-time high on Wednesday

G1 Therapeutics, Inc. (G1H.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

4.2580

+0.0540

(+1.28%)

At close: 08:02AM CEST

Currency in EUR

Valuation Measures⁴

Market Cap (intraday)	224.27M
Enterprise Value	207.47M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.90
Price/Book (mrq)	8.86
Enterprise Value/Revenue	2.66
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	1.71
52-Week Change ³	70.89%
S&P500 52-Week Change ³	26.16%
52 Week High ³	4.5780
52 Week Low ³	1.0350
50-Day Moving Average ³	3.7353
200-Day Moving Average ³	2.4735

Share Statistics

Avg Vol (3 month) ³	152
Avg Vol (10 day) ³	N/A
Shares Outstanding ⁵	52.28M
Implied Shares Outstanding ⁶	53.58M
Float ⁸	43.93M
% Held by Insiders ¹	10.81%
% Held by Institutions ¹	31.01%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	-36.40%
Operating Margin (ttm)	-62.50%

Management Effectiveness

Return on Assets (ttm)	-10.81%
Return on Equity (ttm)	-84.13%

Income Statement

Revenue (ttm)	84.04M
Revenue Per Share (ttm)	1.62
Quarterly Revenue Growth (yoy)	11.80%
Gross Profit (ttm)	N/A
EBITDA	-22.33M
Net Income Avi to Common (ttm)	-30.59M
Diluted EPS (ttm)	-0.5600
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	65.19M
Total Cash Per Share (mrq)	1.25
Total Debt (mrq)	47.09M
Total Debt/Equity (mrq)	169.76%
Current Ratio (mrq)	2.94
Book Value Per Share (mrq)	0.53

Cash Flow Statement

Operating Cash Flow (ttm)	-18.18M
Levered Free Cash Flow (ttm)	-4.94M